Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing-Remitting MS”

241 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 241 results

Post-approval studies (Phase 4)Active Not RecruitingNCT05090371
What this trial is testing

Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Novartis Pharmaceuticals 136
Large-scale testing (Phase 3)Looking for participantsNCT05834855
What this trial is testing

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingDemyelinating Autoimmune Diseases, CNS+3 more
Amsterdam UMC, location VUmc 200
Not applicableStudy completedNCT01925690
What this trial is testing

Development of a Motivational Intervention to Improve Treatment Adherence in MS

Who this might be right for
Relapsing-remitting Multiple Sclerosis
University of Missouri, Kansas City 80
Not applicableUnknownNCT05705986
What this trial is testing

Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

Who this might be right for
Relapse Remitting Multiple Sclerosis
Thomas Jefferson University 40
Not applicableStudy completedNCT01112345
What this trial is testing

An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 133
Testing effectiveness (Phase 2)Active Not RecruitingNCT06800404
What this trial is testing

"HB-adMSCs for the Treatment of Patients With Multiple Sclerosis"

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Multiple Sclerosis
Hope Biosciences Research Foundation 10
Not applicableLooking for participantsNCT06567197
What this trial is testing

Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Amsterdam UMC, location VUmc 24
Not applicableUnknownNCT04993274
What this trial is testing

Sensitivity of Motor Assessment in MS - a Prospective Cohort Study

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Chronic Progressive
Friedemann Paul 100
Not applicableStudy completedNCT00818038
What this trial is testing

A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 30
Testing effectiveness (Phase 2)Study completedNCT01071083
What this trial is testing

Treatment Interruption of Natalizumab

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 175
Early research (Phase 1)Study completedNCT01143441
What this trial is testing

Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS)

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
National Institute of Neurological Disorders and Stroke (NINDS) 48
Testing effectiveness (Phase 2)Ended earlyNCT00035529
What this trial is testing

Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bristol-Myers Squibb
Early research (Phase 1)Study completedNCT00076934
What this trial is testing

Safety of RG2077 in Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT00229502
What this trial is testing

Cognitive Effects of Immunomodulatory Drugs in MS

Who this might be right for
Multiple Sclerosis
Sharon Lynch, MD 96
Post-approval studies (Phase 4)UnknownNCT01417273
What this trial is testing

Impact of Vitamin A on Multiple Sclerosis (MS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Tehran University of Medical Sciences 100
Not applicableUnknownNCT02769767
What this trial is testing

Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Instituto Jalisciense de Cancerologia 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07006805
What this trial is testing

RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis (RMS)Progressive Multiple Sclerosis (PMS)Multiple Sclerosis - Relapsing Remitting+4 more
Cabaletta Bio 12
Large-scale testing (Phase 3)Ended earlyNCT01499667
What this trial is testing

Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Novartis Pharmaceuticals 142
Not applicableStudy completedNCT07273604
What this trial is testing

Psychological Interventions for Multiple Sclerosis: Effects on Anxiety, Depression, and Cognition.

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingAnxietyDepression+3 more
Moisés Bermúdez Hernández 140
Not applicableStudy completedNCT00884481
What this trial is testing

Effects of Tysabri (BG00002) Over 12 Months on MS Related Fatigue in Participants With RRMS

Who this might be right for
Relapsing-Remitting Multiple SclerosisFatigue
Biogen 195
Load More Results